Corporate Restructuring - After years of building its health care business, Du Pont plans to Part with its drug business, a smallish player in an industry in which the leaders have been bulking up through m&a.
|Year of Publication:||
|Type of Publication:||Article|
|Title record from database:|| OLC-SSG Economic Sciences|
|Availability:||More access options|
|More options (other):|
|Description not available.|